CF-301-102 Study Site is a clinical research site located in New Haven, Connecticut, United States 06511.
Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.
CF-301-102 Study Site has participated in 1 clinical trials.
Therapeutic areas: Staphylococcus Aureus Bacteremia, Staphylococcus Aureus Endocarditis.
Sponsors: ContraFect.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Connecticut · View every site in New Haven
Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
CF-301-102 Study Site has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
CF-301-102 Study Site has 1 clinical trials on record. Their work covers Staphylococcus Aureus Bacteremia, Staphylococcus Aureus Endocarditis.
CF-301-102 Study Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.